Highlights Bonesupport Holding AB

Equities

BONEX

SE0009858152

Pharmaceuticals

Market Closed - Nasdaq Stockholm Other stock markets 10:30:00 12/03/2026 pm IST			5-day change	1st Jan Change
194.40 ^SEK	+3.40%		-4.71%	+3.40%

09/03	Lancelot Sverige dipped 1.4 percent in February – lagged behind strong large-cap market	FW
27/02	Bonesupport Publishes Pilot Study on Cerament G Experience in Trauma Care	FW

Highlights

27/02	Bonesupport Announces the First Publication of a US Clinical Pilot Study Reporting on Surgical Technique and Outcomes of CERAMENT G in Trauma	CI
24/02	Bonesupport Holding AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
14/01	Bonesupport expects prelim Q4 revenue at SEK 313 mln	RE
13/01	Bonesupport Holding AB Provides Earnings Guidance for the Fourth Quarter of 2025 and Full Year 2026	CI
02/12	Bonesupport in Talks to Transfer Cerament V Market Application to US FDA's De Novo Process	MT
02/12	BONESUPPORT Announces Change in the Regulatory Process for the Company's Market Application to the U.S. Food and Drug Administration	CI
24/25/24	Bonesupport Holding AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
07/25/07	Bonesupport Shares Plunge as Rumors of Analyst Calls Ahead of Report Are Denied	FW
16/25/16	Bonesuport Announces Positive Results from A Clinical Study Demonstrating Significantly Improved Patient-Based Outcomes for Cerament®? G in Single-Stage Revision Surgery for Patients Patients Lining from Periprosthetic Joint Infection	CI
15/25/15	Bonesupport Holding AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
05/25/05	Bonesupport's Incoming CEO Acquires Shares	RE
27/25/27	Bonesupport Shareholder HealthCap V Distributes 4% Stake	MT
16/25/16	Bonesupport Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
01/25/01	Bonesupport Applies for US FDA Market Authorization for Expanded Use of Bone Filler Device	MT
01/25/01	Bonesupport Holding AB Files FDA Submission for Cerament V	CI
25/25/25	Bonesupport Holding AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024	CI
20/25/20	Adrigo Small & Midcap L/S up 4.07% in December - invested in Paxman	FW
14/25/14	Carnegie Småbolagsfond increased 1.08 percent in December - Mildef, Bonesupport, Truecaller and TF Bank contributed most during the year	FW
13/25/13	Carnegie raises target price for Bonesupport to SEK 450 (390), reiterates Buy - BN	FW
08/25/08	First public blank in years in Bonesupport	FW
07/25/07	Bonesupport reports positive study results for Cerament	FW
07/25/07	Bonesupport announces positive results for Cerament G and Cerament V	FW
07/25/07	Bonesupport Holding AB Announces Study Results for CERAMENT G and CERAMENT V in Surgical Treatment of Bone Infection Due to Diabetic Foot Ulcers	CI
02/25/02	Precise and Isofol 2024 winners on Nasdaq Stockholm, Xbrane and Fingerprint losers of the year	FW
27/24/27	Analysts see continued buying opportunity in Bonesupport - Di	FW